Kyungpook National University Hospital is a national university hospital located in 130 Dongdeok-ro, Jung-gu, Daegu City, South Korea. The first Western medicine was introduced to Daegu city in 1897, at Widespread Relief House.

During the past decade, Kyungpook National University Hospital conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 75 clinical trials were completed, i.e. on average, 34.9% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 57 clinical trials were completed. i.e. 64% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyungpook National University Hospital" #1 sponsor was "Kyungpook National University Hospital" with 36 trials, followed by "Pfizer" with 21 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored, "Takeda" with 14 trials sponsored and "Gilead Sciences" with 14 trials sponsored. Other sponsors include 193 different institutions and companies that sponsored additional 104 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyungpook National University Hospital" #1 collaborator was "Kyungpook National University Hospital" with 16 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Pusan National University Hospital" with 5 trials as a collaborator and "Chonnam National University Hospital" with 4 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 127 trials.

According to Clinical.Site data, the most researched conditions in "Kyungpook National University Hospital" are "Crohn's Disease" (13 trials), "Coronary Artery Disease" (10 trials), "Gastric Cancer" (9 trials), "Ulcerative Colitis" (9 trials) and "Breast Cancer" (8 trials). Many other conditions were trialed in "Kyungpook National University Hospital" in a lesser frequency.

Most popular intervention types in "Kyungpook National University Hospital" are "Drug" (220 trials), "Other" (23 trials), "Biological" (22 trials), "Device" (21 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (59 trials), "Dexamethasone" (7 trials), "Capecitabine" (6 trials), "Atezolizumab" (5 trials) and "Lansoprazole" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kyungpook National University Hospital" are 280 trials for "All" genders, 11 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Kyungpook National University Hospital". undefined are not yet recruiting, 57 are recruiting, 42 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 146 completed trials in Kyungpook National University Hospital, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Kyungpook National University Hospital, 25 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 121 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 38 trials, and there were also 33 trials that are defined as “Not Applicable".